Yigal Nahamavitz
Analyst
Citi
Equibles does not estimate personal net worth.
About Yigal Nahamavitz
Yigal Nahamavitz is recorded as Analyst at Citi. Yigal Nahamavitz has spoken on 2 investor events across 2 companies, most recently for Zenas BioPharma, Inc. on September 9, 2026. Those appearances were for Zenas BioPharma, Inc. (ZBIO) and Lexicon Pharmaceuticals, Inc. (LXRX). The companies whose calls Yigal Nahamavitz spoke on are classified in the Healthcare sector.
Yigal Nahamavitz on recent calls
“This is day one of Citi's Biopharma Back to School Summit here in New York City. I'm Yigal Nahamavitz. I'm one of the biotech analysts. It's my great pleasure to introduce Zenas Biopharma, Lonnie Mulder, Chairman and CEO.”
“We're very pleased to be introducing our next company, Lexicon Pharmaceuticals. We have Mike Exton, CEO. Welcome. And Craig Granowitz, CMO. And Scott Chianti, the CFO.”
Affiliation history
-
Citi
Analyst
Transcript header (unverified)
Current